Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,805,131
-
Share change
-
+715,905
-
Total reported value
-
$11,433,648
-
Put/Call ratio
-
0.67%
-
Price per share
-
$0.61
-
Number of holders
-
55
-
Value change
-
+$112,074
-
Number of buys
-
13
-
Number of sells
-
21
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q4 2023
As of 31 Dec 2023,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,805,131 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, 5AM Venture Management, LLC, VANGUARD GROUP INC, Newtyn Management, LLC, BlackRock Inc., BML Capital Management, LLC, Erste Asset Management GmbH, Vivo Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, and GEORGE KAISER FAMILY FOUNDATION.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.